Anti-Myeloperoxidase Antibodies Associate with Future Proliferative Lupus Nephritis.
S W OlsonJ J LeeM PoirierD J LittleL K PrinceT P BakerJ D EdisonK C AbbottPublished in: Autoimmune diseases (2017)
Subclinical MPO-ANCA levels could distinguish future PLN from SLE without LN. MPO-ANCA manifests prior to clinical disease and subclinical dsDNAab to suggest that it may contribute directly to PLN pathogenicity.